Juventas Therapeutics, Inc.

About Juventas Therapeutics, Inc.

Juventas Therapeutics is a private, clinical stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body. Product candidate JVS-100 is a non-viral gene therapy that expresses stromal cell-derived factor-1, or SDF-1, a naturally occurring signaling protein that has been shown to recruit the body’s own stem cells and promote tissue repair in a broad range of disease states. This therapeutic approach is based on research originating at the Cleveland Clinic. Juventas is currently completing a Phase 2b study in patients with advanced peripheral artery disease.

Write Your Reviews

Writing great reviews may help others discover the places that are just apt for them. Here are a few tips to write a good review:

3 Star

Be the First One To Review This Listing!!!

Company Info

Year Founded
Number of Employees 50 - 99
Minimal Budget $10,000 - $25,000

Our Location

3615 Superior Ave #4403b, Cleveland , Ohio 44114 , United States
View Map